133 related articles for article (PubMed ID: 35421765)
41. Antitumour bis(cyclopentadienyl) metal complexes: titanocene and molybdocene dichloride and derivatives.
Abeysinghe PM; Harding MM
Dalton Trans; 2007 Aug; (32):3474-82. PubMed ID: 17680034
[TBL] [Abstract][Full Text] [Related]
42. Cytotoxic titanium salan complexes: surprising interaction of salan and alkoxy ligands.
Immel TA; Groth U; Huhn T
Chemistry; 2010 Mar; 16(9):2775-89. PubMed ID: 20104550
[TBL] [Abstract][Full Text] [Related]
43. Titanocene anticancer complexes and their binding mode of action to human serum albumin: a computational study.
Sarsam SW; Nutt DR; Strohfeldt K; Watson KA
Metallomics; 2011 Feb; 3(2):152-61. PubMed ID: 21210044
[TBL] [Abstract][Full Text] [Related]
44. Titanium(IV) and vitamin C: aqueous complexes of a bioactive form of Ti(IV).
Buettner KM; Collins JM; Valentine AM
Inorg Chem; 2012 Oct; 51(20):11030-9. PubMed ID: 23016626
[TBL] [Abstract][Full Text] [Related]
45. Cytotoxicity of a Ti(IV) compound is independent of serum proteins.
Tinoco AD; Thomas HR; Incarvito CD; Saghatelian A; Valentine AM
Proc Natl Acad Sci U S A; 2012 Mar; 109(13):5016-21. PubMed ID: 22411801
[TBL] [Abstract][Full Text] [Related]
46. Titanium preferential binding sites in human serum transferrin at physiological concentrations.
Nuevo-Ordoñez Y; Montes-Bayón M; Blanco González E; Sanz-Medel A
Metallomics; 2011 Dec; 3(12):1297-303. PubMed ID: 22041858
[TBL] [Abstract][Full Text] [Related]
47. New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals.
Liboiron BD; Thompson KH; Hanson GR; Lam E; Aebischer N; Orvig C
J Am Chem Soc; 2005 Apr; 127(14):5104-15. PubMed ID: 15810845
[TBL] [Abstract][Full Text] [Related]
48. Differential cytotoxicity induced by the Titanium(IV)Salan complex Tc52 in G2-phase independent of DNA damage.
Pesch T; Schuhwerk H; Wyrsch P; Immel T; Dirks W; Bürkle A; Huhn T; Beneke S
BMC Cancer; 2016 Jul; 16():469. PubMed ID: 27412346
[TBL] [Abstract][Full Text] [Related]
49. Regulation of the aggregation behavior of human islet amyloid polypeptide fragment by titanocene complexes.
Du W; Gong G; Wang W; Xu J
J Biol Inorg Chem; 2017 Oct; 22(7):1065-1074. PubMed ID: 28801867
[TBL] [Abstract][Full Text] [Related]
50. Antitumor reactivity of non-metallocene titanium complexes of oxygen-based ligands: is ligand lability essential?
Shavit M; Peri D; Melman A; Tshuva EY
J Biol Inorg Chem; 2007 Aug; 12(6):825-30. PubMed ID: 17483967
[TBL] [Abstract][Full Text] [Related]
51. Formation of titanium(IV) transferrin by reaction of human serum apotransferrin with titanium complexes.
Messori L; Orioli P; Banholzer V; Pais I; Zatta P
FEBS Lett; 1999 Jan; 442(2-3):157-61. PubMed ID: 9928993
[TBL] [Abstract][Full Text] [Related]
52. A molecular docking study of the interactions between human transferrin and seven metallocene dichlorides.
Güette-Fernández JR; Meléndez E; Maldonado-Rojas W; Ortega-Zúñiga C; Olivero-Verbel J; Parés-Matos EI
J Mol Graph Model; 2017 Aug; 75():250-265. PubMed ID: 28609757
[TBL] [Abstract][Full Text] [Related]
53. Unusual Synergism of Transferrin and Citrate in the Regulation of Ti(IV) Speciation, Transport, and Toxicity.
Tinoco AD; Saxena M; Sharma S; Noinaj N; Delgado Y; Quiñones González EP; Conklin SE; Zambrana N; Loza-Rosas SA; Parks TB
J Am Chem Soc; 2016 May; 138(17):5659-65. PubMed ID: 27070073
[TBL] [Abstract][Full Text] [Related]
54. Redox potentials of Ti(IV) and Fe(III) complexes provide insights into titanium biodistribution mechanisms.
Parker Siburt CJ; Lin EM; Brandt SJ; Tinoco AD; Valentine AM; Crumbliss AL
J Inorg Biochem; 2010 Sep; 104(9):1006-9. PubMed ID: 20569990
[TBL] [Abstract][Full Text] [Related]
55. Study of the cytotoxicity and particle action in human cancer cells of titanocene-functionalized materials with potential application against tumors.
García-Peñas A; Gómez-Ruiz S; Pérez-Quintanilla D; Paschke R; Sierra I; Prashar S; del Hierro I; Kaluđerović GN
J Inorg Biochem; 2012 Jan; 106(1):100-10. PubMed ID: 22112846
[TBL] [Abstract][Full Text] [Related]
56. Synthesis of Pure Enantiomers of Titanium(IV) Complexes with Chiral Diaminobis(phenolato) Ligands and Their Biological Reactivity.
Miller M; Tshuva EY
Sci Rep; 2018 Jun; 8(1):9705. PubMed ID: 29946136
[TBL] [Abstract][Full Text] [Related]
57. Interaction with Blood Proteins of a Ruthenium(II) Nitrofuryl Semicarbazone Complex: Effect on the Antitumoral Activity.
Demoro B; Bento-Oliveira A; Marques F; Costa Pessoa J; Otero L; Gambino D; F M de Almeida R; Tomaz AI
Molecules; 2019 Aug; 24(16):. PubMed ID: 31394747
[TBL] [Abstract][Full Text] [Related]
58. Platinum metallodrug-protein binding studies by capillary electrophoresis-inductively coupled plasma-mass spectrometry: characterization of interactions between Pt(II) complexes and human serum albumin.
Timerbaev AR; Aleksenko SS; Polec-Pawlak K; Ruzik R; Semenova O; Hartinger CG; Oszwaldowski S; Galanski M; Jarosz M; Keppler BK
Electrophoresis; 2004 Jul; 25(13):1988-1995. PubMed ID: 15237398
[TBL] [Abstract][Full Text] [Related]
59. C1-symmetrical titanium(IV) complexes of salan ligands with differently substituted aromatic rings: enhanced cytotoxic activity.
Glasner H; Tshuva EY
Inorg Chem; 2014 Mar; 53(6):3170-6. PubMed ID: 24588655
[TBL] [Abstract][Full Text] [Related]
60. Affinity of a mononuclear monofunctional anticancer Pt(II) complex to human serum albumin: a spectroscopic approach.
Chen Z; Zhang S; Zhang J
Biometals; 2015 Dec; 28(6):1031-41. PubMed ID: 26475326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
